Guardant Health GH 深 沪
等待开盘 11-05 09:30:00 美东时间
98.14
-0.780
-0.79%
华盛通- 最 高100.22
- 今 开93.40
- 成交量 303.65万股
- 最 低 93.05
- 昨 收 98.92
- 总市值 122.68亿
- 52周最高 100.22
- 市盈率 静 --
- 换手率 2.43%
- 52周最低 28.4498
- 委 比 67.98%
- 总股本 1.25亿
- 历史最高 181.07
- 量 比 0.62
- 振 幅 7.25%
- 历史最低 15.81
- 每 手 1
- 风险率 11.77%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Guardant Health Announces $250M Underwritten Public Offering Of Its Common Stock
Guardant Health, Inc. ("Guardant Health") (NASDAQ:GH), a leading precision oncology company, today announced the commencement of an underwritten public offering of $250.0 million of shares of Guardant Health's common
今天 05:41
美股牛股 | CMBM涨超27%！与星链携手推出全新集成网络方案；医疗股GH绩后大涨近28%
CMBM涨超27%！与星链携手推出全新集成网络方案；Q3收入同比增长39%超预期，医疗股GH绩后大涨近28%；MTSR涨超22%，拟获诺和诺德要约收购>>
10-31 14:55
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
This Is Why Guardant Health Stock (GH) Surged 30% Today
Guardant Health ($GH) stock soared 30% today after the precision oncology compa...
10-31 02:36
BTIG Maintains Buy on Guardant Health, Raises Price Target to $100
BTIG analyst Mark Massaro maintains Guardant Health (NASDAQ:GH) with a Buy and raises the price target from $80 to $100.
10-30 18:32
Why Alphabet Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Shares of Alphabet Inc. (NASDAQ:GOOGL) rose sharply in today's pre-market tradi...
10-30 17:38
跑分超330万，骁龙8 Gen5参数曝光，一加Ace6 Pro首发
高通新一代旗舰芯片骁龙8 Gen5 的详细规格正式揭晓，而一加已确认将成为这款芯片的全球首发厂商。这款由一加与高通联合定义、耗时两年研发的旗舰芯片，将搭载于...
10-30 15:57
美股盘后 | Guardant Health涨21.77%
Guardant Health将于10月29日发布2025年三季报，预期每股亏损0.61美元，营收2.3525亿美元。作为液体活检领域领先企业，尽管面临盈利挑战，但其在精准医疗和基因测序领域的发展潜力值得关注。
10-30 07:47
CORRECTION: Guardant Health Q3 Adj. EPS $(0.39) Beats $(0.77) Estimate, Sales $265.196M Beat $235.692M Estimate
Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.39) per share which beat the analyst consensus estimate of $(0.77) by 49.02 percent. This is a 13.33 percent increase over losses of $(0.45) per share from the
10-30 06:04
